BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20971100)

  • 41. Mitochondrial biotransformation of omega-(phenoxy)alkanoic acids, 3-(phenoxy)acrylic acids, and omega-(1-methyl-1H-imidazol-2-ylthio)alkanoic acids: a prodrug strategy for targeting cytoprotective antioxidants to mitochondria.
    Roser KS; Brookes PS; Wojtovich AP; Olson LP; Shojaie J; Parton RL; Anders MW
    Bioorg Med Chem; 2010 Feb; 18(4):1441-8. PubMed ID: 20129794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medium-chain acyl-CoA dehydrogenase- and enoyl-CoA hydratase-dependent bioactivation of 5,6-dichloro-4-thia-5-hexenoyl-CoA.
    Fitzsimmons ME; Thorpe C; Anders MW
    Biochemistry; 1995 Apr; 34(13):4276-86. PubMed ID: 7703241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elimination reactions in the medium-chain acyl-CoA dehydrogenase: bioactivation of cytotoxic 4-thiaalkanoic acids.
    Baker-Malcolm JF; Haeffner-Gormley L; Wang L; Anders MW; Thorpe C
    Biochemistry; 1998 Feb; 37(5):1383-93. PubMed ID: 9477967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nephrotoxicity and hepatotoxicity of 5,6-dichloro-4-thia-5-hexenoic acid: evidence for fatty acid beta-oxidation-dependent bioactivation.
    Fitzsimmons ME; Baggs RB; Anders MW
    J Pharmacol Exp Ther; 1994 Oct; 271(1):515-23. PubMed ID: 7965751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Putting bioactivation reactions to work: Targeting antioxidants to mitochondria.
    Anders MW
    Chem Biol Interact; 2011 Jun; 192(1-2):8-13. PubMed ID: 20971100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploiting endobiotic metabolic pathways to target xenobiotic antioxidants to mitochondria.
    Anders MW
    Mitochondrion; 2013 Sep; 13(5):454-63. PubMed ID: 23123918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemical toxicology of reactive intermediates formed by the glutathione-dependent bioactivation of halogen-containing compounds.
    Anders MW
    Chem Res Toxicol; 2008 Jan; 21(1):145-59. PubMed ID: 17696489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants.
    Cooper AJ
    Neurochem Int; 2004 Jun; 44(8):557-77. PubMed ID: 15016471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential metabolic bioactivation pathways involving cyclic tertiary amines and azaarenes.
    Castagnoli N; Rimoldi JM; Bloomquist J; Castagnoli KP
    Chem Res Toxicol; 1997 Sep; 10(9):924-40. PubMed ID: 9305573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Peroxisomal beta-oxidation].
    Mannaerts GP; Van Veldhoven PP
    Verh K Acad Geneeskd Belg; 1993; 55(1):45-78. PubMed ID: 8480447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitochondrial bioactivation of cysteine S-conjugates and 4-thiaalkanoates: implications for mitochondrial dysfunction and mitochondrial diseases.
    Anders MW
    Biochim Biophys Acta; 1995 May; 1271(1):51-7. PubMed ID: 7599225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics.
    Kalgutkar AS; Dalvie DK; O'Donnell JP; Taylor TJ; Sahakian DC
    Curr Drug Metab; 2002 Aug; 3(4):379-424. PubMed ID: 12093357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Formation of reactive intermediates by phase II enzymes: glutathione-dependent bioactivation reactions.
    Vamvakas S; Anders MW
    Adv Exp Med Biol; 1991; 283():13-24. PubMed ID: 2068979
    [No Abstract]   [Full Text] [Related]  

  • 54. [Mechanisms of bioactivation of xenobiotics under the influence of enzymatic systems of the body].
    Zholdakova ZI; Kharchevnikova NV
    Vestn Ross Akad Med Nauk; 2002; (8):44-9. PubMed ID: 12212380
    [No Abstract]   [Full Text] [Related]  

  • 55. Bioactivation of xenobiotics by flavin-containing monooxygenases.
    Ziegler DM
    Adv Exp Med Biol; 1991; 283():41-50. PubMed ID: 2069015
    [No Abstract]   [Full Text] [Related]  

  • 56. Historical perspectives on conjugation-dependent bioactivation of foreign compounds.
    Miller JA; Surh YJ
    Adv Pharmacol; 1994; 27():1-16. PubMed ID: 8068550
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.